Draegerwerk Ag & Co. Kgaa · XETR:DRW8
Draegerwerk Ag & Co. Kgaa — Drägerwerk AG & Co. KGaA — 9M 2019 Earnings Presentation
18 slides from Draegerwerk Ag & Co. Kgaa's earnings presentation, Oct 30, 2019
Slide 1: Conference call Interim report January 1 to September 30, 2019
ICH WERDE DA SEIN. Conference call Interim report January 1 to September 30, 2019 Lübeck, October 30, 2019
Slide 2: Disclaimer
Disclaimer This presentation does not constitute an offer of securities for sale or a solicitation of an offer to purchase any securities. No money, securities or other consideration is being solicited by this presentation. This presentation contains forward-looking statements regarding the future d
Slide 3: Business Highlights 9M
Business Highlights 9M Net Sales Order intake (currency adjusted) +6.4% +8.9% continued to be positive. Orders on Currency Currency hand roughly on par with prior adjusted adjusted year’s level. 1,899 663 1,729 Order intake (currency adjusted): 613 Q3 +4.3% yoy 9M +3.5% yoy Q3‘18 Q3‘19 9M'18 9M'
Slide 4: Order development in 9M
Order development in 9M Order entry (€ million) Net Sales Group Medical Safety Group America 389 +4.7% +0.7% +13.4% +17.4% Africa, Asia, -5.6% +14.5% +12.3% 531 +0.0% Australia Europe 1,097 +4.8% +1.1% +10.1% +4.7% Group 2,016 +3.5% -1.0% +11.6% +8.9% Growth rates are net of currency effects 4
Slide 5: Business development 9M
Business development 9M Q3 2018 Q3 2019 Change 9M 2018 9M 2019 Change € million € million % € million € million % Net Sales 613.3 662.9 8.1 1,729.1 1,898.8 9.8 % growth -1.2% 8.1% -0.5% 9.8% % growth (FX adjusted) 1.3% 6.4% 3.0% 8.9% Gross margin 42.2% 42.9% 42.4% 42.6% Functional Expenses -262.6 -2
Slide 6: Functional Expenses 9M
Functional Expenses 9M 9M 2018 9M 2019 Change Change net of FX € million € million % % R&D -191.6 -194.3 1.4 0.0 % of Net Sales -11.1% -10.2% Sales & Marketing -431.2 -459.7 6.6 5.5 % of Net Sales -24.9% -24.2% Administration -150.4 -151.2 0.5 -0.1 % of Net Sales -8.7% -8.0% SG&A -581.7 -611.0 5.0 4
Slide 7: Key Figures 9M
Key Figures 9M 9M 2018 9M 2019 Change € million € million % Cashflow from operating activities -42.0 77.4 >+100 Investments 54.0 88.1 63.4 Net financial debt1 69.3 150.8 >+100 Net financial debt 1 /EBITDA 2 0.4 0.7 Capital employed 1 1,283.4 1,436.2 11.9 ROCE (EBIT 2 /Capital employed 1 ) 5.6% 7.0%
Slide 8: Outlook
Outlook 2018 2019e Current forecast 3.9% +1.0 - +4.0 % +4.0 - +6.0 % Net sales (net of currency effects) (net of currency effects) (net of currency effects) EBIT margin 2.4% 1.0 - 3.0 %1 Confirmed in the range Dräger Value Added EUR -26.5 million Confirmed EUR -60 to -10 million 8
Slide 9: Questions & Answers
Questions & Answers Drager 9 Drager. Technik fiir das Leben®
Slide 10: Guidance 2019
Guidance 2019 2018 2019e Current forecast 3.9% +1.0 - +4.0 % +4.0 - +6.0 % Net sales (net of currency effects) (net of currency effects) (net of currency effects) EBIT margin 2.4% 1.0 - 3.0 %1 Confirmed in the range Dräger Value Added EUR -26.5 million Confirmed EUR -60 to -10 million Other forecast
Slide 11: IFRS 16 Impact
IFRS 16 Impact Increase / Improvement as of in € million September 30,2019 EBITDA 34.4 EBIT 3.3 Cash flow from operating activities 31.2 Net financial debt 110.2 Investments 35.2 Capital employed 104.5 11
Slide 12: Business development quarter Segments
Business development quarter Segments Europe Americas Africa, Asia, Australia Dräger Group Q3 2018 Q3 2019 Q3 2018 Q3 2019 Q3 2018 Q3 2019 Q3 2018 Q3 2019 € million € million € million € million € million € million € million € million Order entry 341.9 385.4 135.1 126.3 180.4 184.0 657.4 695.7 Net S
Slide 13: Business development YTD Segments
Business development YTD Segments Europe Americas Africa, Asia, Australia Dräger Group 9M 2018 9M 2019 9M 2018 9M 2019 9M 2018 9M 2019 9M 2018 9M 2019 € million € million € million € million € million € million € million € million Order entry 1,048.5 1,096.7 363.2 388.6 519.5 530.8 1,931.2 2,016.1 N
Slide 14: Business development Medical
Business development Medical Q3 2018 Q3 2019 Change Change 9M 2018 9M 2019 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 427.8 440.2 2.9 1.2 1,242.9 1,244.6 0.1 -1.0 Europe 206.6 229.4 11.0 10.6 619.1 625.2 1.0 1.1 America 95.7 85.1 -11.0 -12.8 249.2 2
Slide 15: Business development Safety
Business development Safety Q3 2018 Q3 2019 Change Change 9M 2018 9M 2019 Change Change € million € million % % (FX adj.) € million € million % % (FX adj.) Order entry 229.7 255.5 11.3 10.0 688.3 771.4 12.1 11.6 Europe 135.3 156.0 15.3 14.5 429.4 471.5 9.8 10.1 America 39.5 41.2 4.4 2.6 114.0 132.0
Slide 16: Cash-flow statement
Cash-flow statement 9M 2018 9M 2019 Change € million € million % Group net profit -34.7 -10.9 68.6 Change in inventories -132.8 -92.1 30.6 Change in receivables 98.4 105.0 6.7 Change in payables -14.3 -8.0 43.8 Depreciation and amortization 63.1 90.4 43.3 Other operating cash flow items -21.7 -6.9 6
Slide 17: Financial calendar 2019
Financial calendar 2019 March 7, 2019 - Final 2018 figures Conference call April 25, 2019 - Report for the first three months 2019 Conference call May 10, 2019 - Annual shareholders' meeting, Lübeck, Germany August 8, 2019 - Report for the first six months 2019 Conference call October 30, 2019 - Rep
Slide 18: Contact
Contact Melanie Kamann Thomas Fischler Corporate Communications Investor Relations Drägerwerk AG & Co. KGaA Drägerwerk AG & Co. KGaA Moislinger Allee 53−55 Moislinger Allee 53−55 23558 Lübeck, Germany 23558 Lübeck, Germany Tel +49 451 882-3998 Tel +49 451 882-2685 Fax +49 451 882-3944 Fax +49 451 88
Drägerwerk AG & Co. KGaA — 9M 2019 Earnings Presentation on 6ix